# OnCo record non-hodgkin-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/non-hodgkin-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "non-hodgkin-lymphoma" ;
  schema:name "Non-Hodgkin lymphoma (all types)"@en ;
  schema:alternateName "Non-Hodgkin Lymphoma"@en, "NHL"@en, "Non-Hodgkin's lymphoma"@en, "Lymphoma (non-Hodgkin)"@en ;
  schema:description "Non-Hodgkin lymphoma is not one disease but a family of about sixty cancers of B cells, T cells or NK cells, from slow-growing follicular lymphoma to aggressive diffuse large B-cell and Burkitt lymphomas. This page is the map; each subtype has its own page with its own treatment."@en ;
  schema:url <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Non-Hodgkin_lymphoma> ;
  schema:citation <https://www.cancer.gov/types/lymphoma>, <https://doi.org/10.3322/caac.21660> ;
  onco:tag "heme", "umbrella" ;
  onco:related <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/waldenstrom/>, <https://onco.cc/cancers/primary-cns-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/hiv-associated-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/btk/>, <https://onco.cc/targets/bcl2/>, <https://onco.cc/targets/cd30/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/polatuzumab-vedotin/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:trials <https://onco.cc/trials/nct03844048/>, <https://onco.cc/trials/nct04002297/>, <https://onco.cc/trials/nct06230224/>, <https://onco.cc/trials/nct05947851/>, <https://onco.cc/trials/nct06084936/>, <https://onco.cc/trials/nct05645107/>, <https://onco.cc/trials/nct07582432/>, <https://onco.cc/trials/nct06082102/>, <https://onco.cc/trials/nct06947967/>, <https://onco.cc/trials/nct06522737/> ;
  onco:pipeline <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/obecabtagene-autoleucel/>, <https://onco.cc/drugs/tqb3702/>, <https://onco.cc/drugs/stp938/> ;
  onco:standardOfCare <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/polatuzumab-vedotin/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/brentuximab-vedotin/> .